Comparability of shuttle walk test with 6-minutes walk test in pulmonary diseases with emphasis on pulmonary arterial hypertension Source: Annual Congress 2013 –Mechanisms contributing to exercise limitation in health and respiratory, cardiac and pulmonary vascular diseases Year: 2013
Physiological response to the six-minute walk test in pulmonary arterial hypertension Source: Eur Respir J 2005; 26: 667-672 Year: 2005
Prognostic significance of 6-minute walk test in non-group 1 pulmonary hypertension Source: Annual Congress 2013 –Pulmonary circulation: chronic thromboembolic pulmonary hypertension, imaging and biomarkers Year: 2013
Prognostic impact of oxygen saturation during the 6-minute walk test in pulmonary arterial hypertension Source: International Congress 2016 – Pulmonary hypertension: the clinic II Year: 2016
The six-minute walking test accompanied by pulse oximetry and ventilation assessment in patients with pulmonary arterial hypertension Source: Annual Congress 2013 –Pulmonary circulation: chronic thromboembolic pulmonary hypertension, imaging and biomarkers Year: 2013
Exercise testing to predict outcome in idiopathic versus associated pulmonary arterial hypertension Source: Eur Respir J 2012; 40: 1410-1419 Year: 2012
Using the six-minute walk test to assess exercise capacity in people with pulmonary hypertension Source: Annual Congress 2012 - Assessment of physical activity, exercise, muscle function and clinical characteristics as outcomes in physiotherapy and rehabilitation Year: 2012
Spiroveloergometry and 6-minute walking test for exercise capacity assessment in patients with primary pulmonary hypertension Source: Eur Respir J 2005; 26: Suppl. 49, 16s Year: 2005
Exercise capacity in chronic obstructive pulmonary disease: Cardiopulmonary exercise testing versus 6-minute walk test Source: International Congress 2019 – Clinical implications of COPD management Year: 2019
Maximal cardiopulmonary exercise testing in mildly symptomatic patients with idiopathic pulmonary arterial hypertension: correlations with 6-min walk distance and resting hemodynamics Source: Annual Congress 2009 - Pulmonary vascular diseases Year: 2009
Comparison of three walking tests to cardiopulmonary exercise tests in the assessment of exercise tolerance in individuals with pulmonary arterial hypertension Source: International Congress 2016 – Physiotherapy interventions and assessment options in hospitalised patients Year: 2016
Six-minute walk test correlates with hemodynamic severity in chronic thromboembolic pulmonary hypertension Source: Eur Respir J 2004; 24: Suppl. 48, 111s Year: 2004
Six-minute walk test: Comparison with cardiopulmonary exercise test performance, lung function and arterial blood gases in patients with bronchiectasis Source: Annual Congress 2011 - Clinical parameters in airway diseases Year: 2011
Is 6-minute walk distance (6MWD) associated with long-term outcomes in pulmonary arterial hypertension (PAH)? Results from SERAPHIN Source: Annual Congress 2013 –Pulmonary circulation: clinical science and treatment Year: 2013
Reproducibility of 6-minute walking test in patients with COPD Source: Eur Respir J 2011; 38: 261-267 Year: 2011
Physiological responses to the 6-min walk test in patients with chronic obstructive pulmonary disease Source: Eur Respir J 2002; 20: 564-569 Year: 2002
Heart rate responses during the 6-minute walk test in pulmonary arterial hypertension Source: Eur Respir J 2006; 27: 114-120 Year: 2006
Relationship between six-minute walk distance and chronic obstructive pulmonary disease assessment test Source: Annual Congress 2012 - Various issues in clinical physiology Year: 2012
Dynamic hyperinflation during the 6-minute walk test and incremental cycling exercise in patients with chronic obstructive pulmonary disease Source: Eur Respir J 2004; 24: Suppl. 48, 121s Year: 2004
Pulmonary hemodynamics during an intermittent exercise test in COPD patients Source: Eur Respir J 2003; 22: Suppl. 45, 405s Year: 2003